Advertisement
Matrix Laboratories
Premium
General
29 February, 2024
Grapevine: KKR mulls JB Pharma sale; Bharti eyes Del Monte JV exit
Private equity firm KKR & Co. is exploring options for a potential sale of its 53.8% controlling stake in Mumbai-based ......
Premium
Healthcare
03 January, 2024
Kotak's second special situations PE fund bankrolling big-ticket pharma acquisition
Kotak Alternate Asset Managers (previously Kotak Investment Advisors), the alternative investment arm of Kotak Group, which hit a first close of ......
Healthcare
03 October, 2023
Matrix Labs founder Nimmagadda Prasad's firm buys Viatris' India API business
Viatris Inc., the result of the merger between Mylan NV and Pfizer Inc.’s Upjohn unit in 2020, has sold two ......
Premium
Healthcare
04 September, 2017
Company watch: Concord Biotech eyes new opportunities after Quadria's backing
Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20 years ago to start his entrepreneurial journey. The Ahmedabad-based biotechnology ......
Advertisement
Recommended for you
Advertisement
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News